Synmosa Biopharma (ROCO:4114) Cyclically Adjusted Book per Share: NT$11.59 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4114 Synmosa Biopharma Corp ROCO:4114
83 GF Score
Price NT$29.70
GF Value NT$33.93
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Synmosa Biopharma Cyclically Adjusted Book per Share?

Synmosa Biopharma ROCO:4114 +1.37% 83 Cyclically Adjusted Book per Share is NT$11.59 as of Dec. 2025. GuruFocus rates ROCO:4114 with a GF Score™ of 83/100 and a GF Value™ of NT$33.93 (Modestly Undervalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Synmosa Biopharma's adjusted book value per share for the three months ended in Dec. 2025 was NT$16.034. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$11.59 for the trailing ten years ended in Dec. 2025.

During the past 12 months, Synmosa Biopharma's average Cyclically Adjusted Book Growth Rate was 9.30% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 10.00% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 12.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Synmosa Biopharma was 13.90% per year. The lowest was 10.00% per year. And the median was 12.00% per year.

As of today (2026-07-21), Synmosa Biopharma's current stock price is NT$29.70. Synmosa Biopharma's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2025 was NT$11.59. Synmosa Biopharma's Cyclically Adjusted PB Ratio of today is 2.56.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Synmosa Biopharma was 4.18. The lowest was 1.39. And the median was 2.60.


Synmosa Biopharma  (ROCO:4114) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Synmosa Biopharma's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=29.70/11.59
=2.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Synmosa Biopharma was 4.18. The lowest was 1.39. And the median was 2.60.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Synmosa Biopharma Cyclically Adjusted Book per Share Related Terms


Synmosa Biopharma Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Synmosa Biopharma's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Synmosa Biopharma Cyclically Adjusted Book per Share Chart

Synmosa Biopharma Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.59 8.70 9.70 10.60 11.59

Synmosa Biopharma Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.60 10.90 11.17 11.43 11.59

ROCO:4114 vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Synmosa Biopharma's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Synmosa Biopharma Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Synmosa Biopharma's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Synmosa Biopharma's Cyclically Adjusted PB Ratio falls into.


ROCO:4114
83GF Score
Synmosa Biopharma Corp ROCO:4114
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Synmosa Biopharma Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Synmosa Biopharma's adjusted Book Value per Share data for the three months ended in Dec. 2025 was:

Adj_Book= Book Value per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=16.034/324.0540*324.0540
=16.034

Current CPI (Dec. 2025) = 324.0540.

Synmosa Biopharma Quarterly Data

Book Value per Share CPI Adj_Book
201603 6.328 238.132 8.611
201606 6.517 241.018 8.762
201609 6.911 241.428 9.276
201612 6.964 241.432 9.347
201703 7.063 243.801 9.388
201706 6.863 244.955 9.079
201709 6.996 246.819 9.185
201712 6.863 246.524 9.021
201803 8.022 249.554 10.417
201806 7.982 251.989 10.265
201809 8.221 252.439 10.553
201812 7.885 251.233 10.171
201903 7.896 254.202 10.066
201906 7.844 256.143 9.924
201909 7.986 256.759 10.079
201912 7.864 256.974 9.917
202003 7.921 258.115 9.945
202006 9.084 257.797 11.419
202009 9.228 260.280 11.489
202012 9.419 260.474 11.718
202103 9.339 264.877 11.425
202106 9.496 271.696 11.326
202109 9.593 274.310 11.333
202112 9.923 278.802 11.534
202203 10.000 287.504 11.271
202206 10.659 296.311 11.657
202209 10.841 296.808 11.836
202212 11.211 296.797 12.241
202303 11.058 301.836 11.872
202306 12.678 305.109 13.465
202309 12.919 307.789 13.602
202312 13.270 306.746 14.019
202403 13.223 312.332 13.719
202406 13.681 314.175 14.111
202409 14.001 315.301 14.390
202412 14.260 315.605 14.642
202503 15.149 319.799 15.351
202506 15.408 322.561 15.479
202509 15.874 324.800 15.838
202512 16.034 324.054 16.034

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of NT$11.59 mean?
Synmosa Biopharma (ROCO:4114) has a Cyclically Adjusted Book per Share of NT$11.59 as of Dec. 2025. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Synmosa Biopharma and its competitors.
Is Synmosa Biopharma's Cyclically Adjusted Book per Share too high?
Synmosa Biopharma's current Cyclically Adjusted Book per Share is NT$11.59. Overall, Synmosa Biopharma has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Synmosa Biopharma's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Synmosa Biopharma's Cyclically Adjusted Book per Share of NT$11.59 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Synmosa Biopharma and its competitors. Synmosa Biopharma's current Cyclically Adjusted Book per Share is NT$11.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synmosa Biopharma stock overvalued right now?
Based on GuruFocus' analysis, Synmosa Biopharma (ROCO:4114) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$33.93, compared to a current price of NT$29.70 — trading 12.5% below its estimated fair value. The current Cyclically Adjusted Book per Share is NT$11.59. Synmosa Biopharma's overall GF Score™ is 83/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Synmosa Biopharma (ROCO:4114), the current Cyclically Adjusted Book per Share is NT$11.59 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Synmosa Biopharma (ROCO:4114) Overvalued in 2026?

Based on GuruFocus' analysis, Synmosa Biopharma stock appears to be undervalued. The current stock price of NT$29.70 is trading 12.5% below its estimated GF Value™ of NT$33.93. GuruFocus considers Synmosa Biopharma to be Modestly Undervalued.

Key valuation signals for ROCO:4114:

  • Cyclically Adjusted Book per Share: NT$11.59
  • GF Value™: NT$33.93 vs. price of NT$29.70 (12.5% below fair value)
  • GF Score™: 83/100 with 1 warning sign

No single metric tells the full story. See the ROCO:4114 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Synmosa Biopharma Business Description

Address No. 6, Gongye 1st Road, Hukou Township, Hsinchu County, Hsinchu, TWN
Synmosa Biopharma Corp is engaged in pharmaceuticals and medical devices, cosmetics, animal drugs, chemical food additives, beverages manufacturing and sales, and environmental drugs wholesale (retail), as well as the import and export of related businesses. Its segments include the Active Pharmaceutical Ingredients segment and the Generic Drugs segment. The Generic Drugs segment derives the majority of the revenue.
83GF Score

Get the complete analysis for ROCO:4114

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$29.70
Price
NT$33.93
GF Value